Immix Biopharma (IMMX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $7.98, -8.06% vs the prior close of $8.68.
- Volume 1.50M shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
IMMX slides 8.1% to $7.98, a 3-month low. Closed at $7.98, -8.06% vs the prior close of $8.68. Day range $7.95–$8.67, opened at $8.67.
IMMX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — IMMX slides 8.1% to $7.98, a 3-month low
- Closed at $7.98, -8.06% vs the prior close of $8.68. Day range $7.95–$8.67, opened at $8.67.
- Volume was 1.50M shares, 0.9x its 50-day average of 1.59M.
- Price is -31.6% vs its 50-day average ($11.66) and -14.4% vs its 200-day average ($9.32).
- 52-week range $2.61–$15.10; today's close sits at 43% of that range, 47.2% below the 52-week high.
Oct 15, 2026 — IMMX rises 2.0% to $8.68
- Closed at $8.68, +2.00% vs the prior close of $8.51. Day range $8.45–$8.90, opened at $8.51.
- Volume was 1.31M shares, 0.8x its 50-day average of 1.59M.
- Price is -25.8% vs its 50-day average ($11.70) and -6.7% vs its 200-day average ($9.31).
- 52-week range $2.48–$15.10; today's close sits at 49% of that range, 42.5% below the 52-week high.
Oct 14, 2026 — IMMX dips 2.1% to $8.51, a 1-month low, 3 down days in a row
- Closed at $8.51, -2.07% vs the prior close of $8.69. Day range $8.42–$8.87, opened at $8.60.
- Volume was 1.36M shares, 0.8x its 50-day average of 1.60M.
- Price is -27.4% vs its 50-day average ($11.72) and -8.4% vs its 200-day average ($9.29).
- 52-week range $2.31–$15.10; today's close sits at 48% of that range, 43.6% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — IMMX slides 6.1% to $8.69, a 1-month low
- Closed at $8.69, -6.05% vs the prior close of $9.25. Day range $8.66–$9.29, opened at $9.10.
- Volume was 1.48M shares, 0.9x its 50-day average of 1.61M.
- Price is -26.0% vs its 50-day average ($11.74) and -6.3% vs its 200-day average ($9.28).
- 52-week range $2.31–$15.10; today's close sits at 50% of that range, 42.5% below the 52-week high.
Oct 12, 2026 — IMMX dips 2.2% to $9.25, a 1-month low
- Closed at $9.25, -2.22% vs the prior close of $9.46. Day range $9.18–$9.56, opened at $9.42.
- Volume was 936.20K shares, 0.6x its 50-day average of 1.62M — lighter than usual.
- Price is -21.2% vs its 50-day average ($11.73) and -0.1% vs its 200-day average ($9.26).
- 52-week range $2.31–$15.10; today's close sits at 54% of that range, 38.7% below the 52-week high.
Oct 9, 2026 — IMMX rises 1.8% to $9.46
- Closed at $9.46, +1.83% vs the prior close of $9.29. Day range $9.18–$9.53, opened at $9.29.
- Volume was 1.11M shares, 0.7x its 50-day average of 1.62M.
- Price is -19.2% vs its 50-day average ($11.71) and +2.3% vs its 200-day average ($9.24).
- 52-week range $2.31–$15.10; today's close sits at 56% of that range, 37.4% below the 52-week high.
Oct 8, 2026 — IMMX dips 2.1% to $9.29, a 1-month low, 3 down days in a row
- Closed at $9.29, -2.11% vs the prior close of $9.49. Day range $8.96–$9.37, opened at $9.34.
- Volume was 1.29M shares, 0.8x its 50-day average of 1.62M.
- Price is -20.6% vs its 50-day average ($11.70) and +0.7% vs its 200-day average ($9.23).
- 52-week range $2.31–$15.10; today's close sits at 55% of that range, 38.5% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — IMMX dips 1.6% to $9.49, a 1-month low
- Closed at $9.49, -1.56% vs the prior close of $9.64. Day range $9.40–$9.69, opened at $9.50.
- Volume was 1.38M shares, 0.8x its 50-day average of 1.63M.
- Price is -18.7% vs its 50-day average ($11.67) and +3.1% vs its 200-day average ($9.21).
- 52-week range $2.26–$15.10; today's close sits at 56% of that range, 37.2% below the 52-week high.
Oct 6, 2026 — IMMX slides 4.8% to $9.64, a 1-month low
- Closed at $9.64, -4.84% vs the prior close of $10.13. Day range $9.52–$10.20, opened at $10.20.
- Volume was 1.21M shares, 0.7x its 50-day average of 1.65M.
- Price is -17.3% vs its 50-day average ($11.65) and +4.9% vs its 200-day average ($9.19).
- 52-week range $2.00–$15.10; today's close sits at 58% of that range, 36.2% below the 52-week high.
Oct 5, 2026 — IMMX jumps 4.6% to $10.13
- Closed at $10.13, +4.65% vs the prior close of $9.68. Day range $9.55–$10.33, opened at $9.71.
- Volume was 1.60M shares, 1.0x its 50-day average of 1.66M.
- Price is -12.9% vs its 50-day average ($11.63) and +10.5% vs its 200-day average ($9.17).
- 52-week range $2.00–$15.10; today's close sits at 62% of that range, 32.9% below the 52-week high.
Oct 2, 2026 — IMMX slides 5.4% to $9.68, a 1-month low, 4 down days in a row
- Closed at $9.68, -5.38% vs the prior close of $10.23. Day range $9.48–$10.37, opened at $10.35.
- Volume was 2.55M shares, 1.6x its 50-day average of 1.63M.
- Price is -16.6% vs its 50-day average ($11.60) and +5.8% vs its 200-day average ($9.15).
- 52-week range $2.00–$15.10; today's close sits at 59% of that range, 35.9% below the 52-week high.
- That makes 4 straight losses.
IMMX latest news & SEC filings
Every SEC filing by or about IMMX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 29, 2026 · Form FWP — Free writing prospectus (offering marketing material)
Free writing prospectus (offering marketing material)
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 29, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 7, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$11.56M (prior year -$6.62M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.18 (prior year -$0.22) (loss narrowed vs Jun 30, 2025)
Jul 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade IMMX
- How much it moves: over the last 20 sessions the average daily move was 3.73% (largest 8.1%). That is a volatile stock.
- Liquidity: about 1.67M shares (≈$13.31M) trade per day on average.
- 52-week position: $7.98 vs a range of $2.61–$15.10 (43% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 0 sales; latest: Gabriel S Morris bought 770 shares on Dec 10, 2025.
- Latest filings: 8-K Sep 30, 2026; 8-K Sep 29, 2026; 10-Q Aug 7, 2026.
- Share count: 71.54M shares outstanding (Aug 3, 2026), +148.1% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
IMMX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 8.67 | 8.67 | 7.95 | 7.98 | 1.50M |
| Oct 15, 2026 | 8.51 | 8.90 | 8.45 | 8.68 | 1.31M |
| Oct 14, 2026 | 8.60 | 8.87 | 8.42 | 8.51 | 1.36M |
| Oct 13, 2026 | 9.10 | 9.29 | 8.66 | 8.69 | 1.48M |
| Oct 12, 2026 | 9.42 | 9.56 | 9.18 | 9.25 | 936.20K |
| Oct 9, 2026 | 9.29 | 9.53 | 9.18 | 9.46 | 1.11M |
| Oct 8, 2026 | 9.34 | 9.37 | 8.96 | 9.29 | 1.29M |
| Oct 7, 2026 | 9.50 | 9.69 | 9.40 | 9.49 | 1.38M |
| Oct 6, 2026 | 10.20 | 10.20 | 9.52 | 9.64 | 1.21M |
| Oct 5, 2026 | 9.71 | 10.33 | 9.55 | 10.13 | 1.60M |
| Oct 2, 2026 | 10.35 | 10.37 | 9.48 | 9.68 | 2.55M |
| Oct 1, 2026 | 10.25 | 10.48 | 9.86 | 10.23 | 1.65M |
| Sep 30, 2026 | 10.61 | 11.25 | 10.39 | 10.40 | 2.41M |
| Sep 29, 2026 | 11.64 | 11.85 | 10.07 | 10.54 | 5.76M |
| Sep 28, 2026 | 10.82 | 11.84 | 10.70 | 11.47 | 995.60K |
| Sep 25, 2026 | 11.78 | 11.99 | 10.82 | 10.97 | 1.83M |
| Sep 24, 2026 | 11.87 | 11.97 | 11.19 | 11.70 | 1.54M |
| Sep 23, 2026 | 12.80 | 12.84 | 11.71 | 11.92 | 1.17M |
| Sep 22, 2026 | 12.45 | 12.90 | 12.31 | 12.83 | 948.10K |
| Sep 21, 2026 | 12.59 | 12.71 | 12.14 | 12.47 | 1.33M |
About Immix Biopharma
Immix Biopharma (IMMX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in LOS ANGELES, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1873835.
IMMX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Helen C. Adams | Director | May 29, 2026 |
| Jane Buchan | Director | May 29, 2026 |
| Nancy T Chang | Director | May 29, 2026 |
| Yekaterina Chudnovsky | Director | May 29, 2026 |
| Jason Hsu | Director | May 29, 2026 |
| Magda Marquet | Director | May 29, 2026 |
| Gabriel S Morris | CFO, President | May 29, 2026 |
| Carey Ng | Director | May 29, 2026 |
| Ilya M Rachman | CEO and Chairman | May 29, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Gabriel S Morris | CFO, President | May 29, 2026 |
| Ilya M Rachman | CEO and Chairman | May 29, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Dec 10, 2025 | Gabriel S Morris | Buy | 770 | $6.58 |
| Dec 10, 2025 | Gabriel S Morris | Buy | 770 | $6.58 |
| Dec 10, 2025 | Gabriel S Morris | Buy | 770 | $6.58 |
| Dec 10, 2025 | Gabriel S Morris | Buy | 770 | $6.58 |
| Dec 10, 2025 | Ilya M Rachman | Buy | 746 | $6.67 |
| Dec 10, 2025 | Ilya M Rachman | Buy | 746 | $6.67 |
| Dec 10, 2025 | Ilya M Rachman | Buy | 746 | $6.67 |
| Dec 10, 2025 | Ilya M Rachman | Buy | 746 | $6.67 |
IMMX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-29.44M | -0.89 | $-23.93M |
| Dec 31, 2024 | — | $-21.61M | -0.76 | $-14.60M |
| Dec 31, 2023 | — | $-15.43M | -0.89 | $-11.37M |
| Dec 31, 2022 | — | $-8.23M | -0.59 | $-7.41M |
| Dec 31, 2021 | — | $-24.38M | — | $-1.59M |
Latest balance sheet: total assets $239.11M, total liabilities $10.19M, cash $225.49M (as of Jun 30, 2026).
IMMX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on IMMX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.